Trial Profile
Safety, immunogenicity and evidence of effect of vaccine candidate CIGB-247 in the treatment of hepatocellular carcinoma.
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs CIGB 247 (Primary) ; Aluminium phosphate
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms CENTAURO-6
- 08 Mar 2017 New trial record